hospitalized COVID-19 patients
[용어속성] Patient
Clinical characteristics and prognosis of hospitalized COVID-19 patients with incident sustained tachyarrhythmias: A multicenter observational study
Observational Study
[키워드] ARDS
arrhythmia
Arrhythmias
association
Atrial fibrillation
baseline characteristics
Characteristics
clinical
collected
consecutive patient
correlation
COVID-19
Covid-19 and arrhythmia
Covid-19 and cardiovascular complications
Covid-19 and cardiovascular System
death
disease severity
evaluate
evaluated
Follow-up
hospitalized COVID-19 patient
hospitalized COVID-19 patients
hospitalized patient
in-hospital mortality
incidence
incident
independent
Italian
Laboratory
male
material
median
multicenter
multicenter observational study
not affect
observation
predictor
Prevalence
prevalent
Prognosis
prognostic
retrospective
risk
SARS-CoV-2
SARSCoV-2
SARSCoV-2 and ventricular arrhythmias.
severe adverse event
significantly increased
supraventricular
sustained
ventricular
with COVID-19
[DOI] 10.1111/eci.13387 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1111/eci.13387 PMC 바로가기 [Article Type] Observational Study
COVID-19, myocardial edema and dexamethasone
COVID-19, 심근 부종 및 덱사메타손
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
Antiviral
antiviral agent
ARDS
cause of death
Corona virus
coronavirus
coronavirus disease
COVID-19
cytokine
Cytokine storm syndrome
death
develop
Dexamethasone
Dyspnea
edema
effective
endothelial
FDA
gcs
glucocorticoid
Glucocorticoids
high mortality rate
Hospitalized
hospitalized COVID-19 patients
Hypoxemia
kidney
lead
Liver injury
Myocardial
Myocardium
Numerous
Patient
patient with COVID-19
poor prognosis
progression
randomized trial
reducing mortality
respiratory
respiratory distress
Respiratory failure
Safe
Severe acute respiratory syndrome
Severe Acute Respiratory Syndrome Corona Virus
severe COVID-19
stability
syndrome
therapeutic effect
therapeutic effects
tissue
Treatment
Vascular
vascular permeability
virus
[DOI] 10.1016/j.mehy.2020.110307 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.mehy.2020.110307 PMC 바로가기 [Article Type] Article
Clinical Characteristics of Stroke with COVID-19: A Systematic Review and Meta-Analysis
COVID-19에 의한 뇌졸중의 임상적 특징: 체계적인 검토 및 메타 분석
Meta-Analysis
Published on
Journal: Journal of stroke and cerebrovascular diseases : t [Category] Coronavirus, MERS, 바이오마커,
Journal: Journal of stroke and cerebrovascular diseases : t [Category] Coronavirus, MERS, 바이오마커,
[키워드] age
Care
Case fatality rate
Case report
Characteristics
clinical
Clinical characteristics
Comorbidities
confidential interval
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
Cross-sectional studies
D-dimer
effective
elevated
estimate
etiology
Frequency
high mortality
hospitalized COVID-19 patient
hospitalized COVID-19 patients
increase
increased risk
male
Meta-analysis
Numerous
Older age
outcome
pathophysiology
patients
patients with COVID-19
Prognosis
random-effects model
retrospective
retrospective cohort study
review
risk
Risk factors
SARS-CoV2
searched
stroke
stroke risk
Support
symptom onset
systematic review
Thromboembolism
Treatment
[DOI] 10.1016/j.jstrokecerebrovasdis.2020.105288 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1016/j.jstrokecerebrovasdis.2020.105288 PMC 바로가기 [Article Type] Meta-Analysis
Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study
Research Article
[키워드] age
Analysis
Belgium
Care
Chinese
Clinical characteristics
cohorts
Complication
coronavirus
coronavirus disease
country
COVID-19
COVID-19 patient
death
described
Diagnosis
effective
Europe
European
Factor
Fatality rate
good quality
Hospitalized
hospitalized COVID-19 patients
hospitalized patient
identify
in-hospital mortality
increased risk
intensive care
Invasive mechanical ventilation
IQR
lactate dehydrogenase
lower mortality
male
Mortality
Most patient
multivariate logistic regression
Older age
outcome
pandemic
Patient
patients with obesity
predictor
preventative measures
renal
Result
retrospective cohort study
risk factor
severe disease
supplementary material
the epidemic
the median
therapeutic
United State
Univariate analysis
with COVID-19
[DOI] 10.1186/s12879-020-05605-3 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s12879-020-05605-3 PMC 바로가기 [Article Type] Research Article
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study
Medicine
[키워드] acute respiratory distress
acute respiratory distress syndrome
anticoagulant therapy
bleeding event
Clinical characteristics
clinical impact
Clinical prognosis
clinically
COVID-19
COVID-19 patient
COVID-19 patients
cumulative
death
decreased mortality
Deep venous thrombosis
drug
Effectiveness
Efficacy
enoxaparin
enrolled
evaluate
event
Evidence
FIVE
Follow-up
fondaparinux
heparin
hospital
Hospitalized
hospitalized COVID-19 patients
hospitalized patient
incidence
incidence rate
interquartile
Italian
Laboratory
major bleeding
major bleedings
median
multicenter
observation
outcome
pharmacological
Prophylaxis
Prospective Study
provide
Pulmonary embolism
Regression model
retrospective
risk
Safe
setting
severe coronavirus disease
shown
significant difference
significant differences
statistically significant difference
symptomatic patient
syndrome
therapy
Thromboprofylaxis
Thromboprophylaxis
two group
Venous Thromboembolism
VTE
[DOI] 10.3389/fmed.2020.569567 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.569567 PMC 바로가기 [Article Type] Medicine
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
종단 단백질 프로파일링은 심각한 COVID-19에서 증가된 초기 염증 및 지속적인 세포자멸사 단백질을 보여줍니다
Article
[키워드] addition
age
antibodies
Apoptosis
apoptotic pathway
Blood
CASP8
CCL2
CCL7
CCL8
chemokines
cohorts
COVID-19
COVID-19 disease
CXCL10
CXCL11
Cytokines
defined
develop
disease severity
Factor
HGF
hospitalized COVID-19 patient
hospitalized COVID-19 patients
Host
hypertension
ICU
ICU admission
ICU Patients
IFNγ
IL-10
IL-6
Inflammation
inflammation markers
Inflammatory
inflammatory condition
Inflammatory marker
inflammatory markers
intensive care
intensive care unit
life-threatening COVID-19 disease
longitudinal
marker
Molecular medicine
monocyte
neutralization capacity
non-ICU
Patient
plasma protein
plasma proteins
Protein
proteomic
reveal
risk
Risk factors
SARS-COV-2 infection
SARS-CoV-2-specific antibodies
SARS-CoV-2-specific antibody
selective
severe COVID-19
specific antibodies
Stratification
sustained
TGFB1
TNFSF14
Treatment
upregulation
viral infection
while
[DOI] 10.1038/s41598-020-77525-w PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-020-77525-w PMC 바로가기 [Article Type] Article
C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19
코로나19로 입원한 환자의 예후 지표로서의 C 반응성 단백질
Research Article
[키워드] Admission
Analysis
association
conducted
COVID
CRP
CRP level
CRP levels
CRP value
CRP values
declines
died
Disease progression
elevated
entire cohort
facilitate
Hospitalization
hospitalized COVID-19 patient
hospitalized COVID-19 patients
hospitalized patient
ICU
ICU admission
in-hospital mortality
IQR
linear
median
medical record
medical records
Patient
patients
patients with COVID-19
peaked
prognostic indicator
progression
Protein
recent
reported
retrospective cohort
risk stratification
Seven
Severity of disease
significantly higher
Support
System
the median
the patient
those who survived
threshold
utility
with COVID-19
[DOI] 10.1371/journal.pone.0242400 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0242400 PMC 바로가기 [Article Type] Research Article
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
COVID-19 치료를 위한 항암제의 용도 변경
Review
[키워드] adverse event
adverse events
allergy
anti-cancer drugs
benefit
Cancer
catastrophic
caused
Cell
cell division
center
clinical trials
compassionate use
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
de novo
died
drug
Drug development
Drug discovery
drug-repurposing.
effective drug
effective drugs
Efficacy
effort
FDA
focus
food
Food and Drug Administration
globe
hospitalized COVID-19 patients
Host
Infectious disease
Infectious diseases
Inflammation
inhibiting
Johns Hopkins
Johns Hopkins University
life
microenvironment
modulating
NIAID
Novel coronavirus
novel coronavirus disease
novel vaccines
pandemic
present
promise
randomized study
Remdesivir
repurposing
scarcity
shown
tested
the disease
Therapies
Treatment
Vaccine
Vaccines
[DOI] 10.2147/DDDT.S282252 PMC 바로가기 [Article Type] Review
[DOI] 10.2147/DDDT.S282252 PMC 바로가기 [Article Type] Review
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
Meta-Analysis
Published on
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 임상, 진단,
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 임상, 진단,
[키워드] 95%CI
adjusted
adjusted RR
adverse event
approach
association
certainty of evidence
citation
Cohort
cohort study
cohorts
concerning
Controlled
COVID-19
COVID-19 patients
COVID-19 severity
Daily
death
did not reduce
Efficacy
elevated
eligibility criteria
eligible
evaluate
evaluated
Evidence
examined
FIVE
Google
higher risk
hospitalized COVID-19 patients
IL-6
IL-6 receptor
Infection
interleukin-6
lower mortality
mechanical ventilation
Meta-analysis
moderate
Mortality
Multiorgan
objective
observational study
observé
Other
OVID
participant
Patient
patients
Placebo
Randomized controlled trial
RCT
RCTs
reduce
Result
risk
risk of bia
Risk of bias
risk ratio
RRs
severe coronavirus disease
Standard of care
syndrome
systematic review
Tocilizumab
Toxicity
treat
Treatment
Web of Science
while
[DOI] 10.1016/j.cmi.2020.10.036 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1016/j.cmi.2020.10.036 PMC 바로가기 [Article Type] Meta-Analysis